Intellia Therapeutics, Inc.

It is a biotechnology company developing biopharmaceuticals using a CRISPR gene editing system.

NTLA Nasdaq SEC CIK 1652130

Follow Intellia Therapeutics Weekly email: filings, results, news

News

3 stories filed under Intellia Therapeutics

Thread · 2 stories

Markets 15 d ago 2 sources

Markets 16 d ago

Earnings 48 d ago 2 sources

NOV5

Q1 2026 results

Thursday · estimated from the filing cadence

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 3 stories clustered from the RSS aggregator